Loading...
XLONSPI
Market cap1.14bUSD
Dec 24, Last price  
226.50GBP
1D
1.57%
1Q
-3.21%
Jan 2017
-32.93%
IPO
7.86%
Name

Spire Healthcare Group PLC

Chart & Performance

D1W1MN
XLON:SPI chart
P/E
3,339.75
P/S
67.09
EPS
0.07
Div Yield, %
0.00%
Shrs. gr., 5y
0.54%
Rev. gr., 5y
7.86%
Revenues
1.36b
+13.39%
674,000,000738,900,000764,500,000856,000,000884,800,000926,400,000931,700,000931,100,000980,800,000919,900,0001,106,200,0001,198,500,0001,359,000,000
Net income
27m
+217.44%
-22,300,000-130,000,000102,200,0006,000,00060,000,00053,600,00016,800,000100,0007,200,000-233,900,000-9,700,0008,600,00027,300,000
CFO
200m
+24.55%
194,600,000176,800,00099,700,000113,000,000155,300,000177,400,000124,000,000182,600,000184,500,000141,700,000170,600,000160,500,000199,900,000
Dividend
May 23, 20242.1 GBP/sh
Earnings
Feb 26, 2025

Profile

Sierra Rutile Holdings Limited engages in the multi-mine mineral sands operation in southern Sierra Leone. It holds interests in mineral sand deposits located in Moyamba and Bonthe districts in Sierra Leone; and the Sembehun project located in Moyamba district in Sierra Leone. The company was incorporated in 2016 and is based in Perth, Australia. Sierra Rutile Holdings Limited operates independently of Iluka Resources Limited as of August 4, 2022.
URL
https://www.spirehealthcare.com/
IPO date
Jul 18, 2014
Employees
2,000
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,359,000
13.39%
1,198,500
8.34%
1,106,200
20.25%
Cost of revenue
838,400
758,000
712,100
Unusual Expense (Income)
NOPBT
520,600
440,500
394,100
NOPBT Margin
38.31%
36.75%
35.63%
Operating Taxes
6,700
(4,300)
7,000
Tax Rate
1.29%
1.78%
NOPAT
513,900
444,800
387,100
Net income
27,300
217.44%
8,600
-188.66%
(9,700)
-95.85%
Dividends
(2,000)
(100)
Dividend yield
0.21%
0.01%
Proceeds from repurchase of equity
(3,700)
(90,300)
BB yield
0.40%
9.61%
Debt
Debt current
101,800
95,700
92,500
Long-term debt
2,046,900
1,095,100
1,172,800
Deferred revenue
1
1,095,100
1,172,800
Other long-term liabilities
9,600
(321,400)
(421,800)
Net debt
2,098,700
1,107,000
1,060,400
Cash flow
Cash from operating activities
199,900
160,500
170,600
CAPEX
(84,400)
(87,700)
(69,300)
Cash from investing activities
(157,200)
(98,000)
(48,300)
Cash from financing activities
(82,900)
(190,900)
(26,000)
FCF
479,500
413,900
368,900
Balance
Cash
49,600
74,200
202,600
Long term investments
400
9,600
2,300
Excess cash
23,875
149,590
Stockholders' equity
(91,500)
(104,900)
(121,300)
Invested Capital
2,095,900
2,019,300
2,088,300
ROIC
24.98%
21.66%
18.95%
ROCE
25.12%
22.35%
19.46%
EV
Common stock shares outstanding
413,144
412,043
400,848
Price
2.27
-0.66%
2.28
-8.80%
2.50
60.88%
Market cap
935,770
-0.39%
939,458
-6.25%
1,002,121
60.88%
EV
3,032,370
2,040,558
2,057,721
EBITDA
624,200
538,400
491,200
EV/EBITDA
4.86
3.79
4.19
Interest
93,000
91,500
87,000
Interest/NOPBT
17.86%
20.77%
22.08%